Search

Stephen Gucker

Examiner (ID: 13993)

Most Active Art Unit
1649
Art Unit(s)
1812, 1649, 1645, 1646, 1818, 1647
Total Applications
799
Issued Applications
370
Pending Applications
114
Abandoned Applications
315

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 435797 [patent_doc_number] => 07262052 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-08-28 [patent_title] => 'α-2/δ gene' [patent_app_type] => utility [patent_app_number] => 09/787657 [patent_app_country] => US [patent_app_date] => 1999-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16536 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/262/07262052.pdf [firstpage_image] =>[orig_patent_app_number] => 09787657 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/787657
α-2/δ gene Oct 6, 1999 Issued
Array ( [id] => 1515449 [patent_doc_number] => 06420532 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-16 [patent_title] => 'Method of obtaining compositions comprising Y2 specific compounds' [patent_app_type] => B1 [patent_app_number] => 09/407367 [patent_app_country] => US [patent_app_date] => 1999-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 48 [patent_no_of_words] => 34298 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/420/06420532.pdf [firstpage_image] =>[orig_patent_app_number] => 09407367 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/407367
Method of obtaining compositions comprising Y2 specific compounds Sep 28, 1999 Issued
Array ( [id] => 1208974 [patent_doc_number] => 06713265 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-30 [patent_title] => 'Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)' [patent_app_type] => B1 [patent_app_number] => 09/194895 [patent_app_country] => US [patent_app_date] => 1999-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 47 [patent_no_of_words] => 51901 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/713/06713265.pdf [firstpage_image] =>[orig_patent_app_number] => 09194895 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/194895
Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) Sep 26, 1999 Issued
Array ( [id] => 386660 [patent_doc_number] => 07304029 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-12-04 [patent_title] => 'Neuroprotective effect of growth hormone' [patent_app_type] => utility [patent_app_number] => 09/786982 [patent_app_country] => US [patent_app_date] => 1999-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8049 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/304/07304029.pdf [firstpage_image] =>[orig_patent_app_number] => 09786982 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/786982
Neuroprotective effect of growth hormone Sep 2, 1999 Issued
09/378567 USES OF TGFA AND RELATED POLYPEPTIDES Aug 18, 1999 Abandoned
Array ( [id] => 1516991 [patent_doc_number] => 06500638 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-12-31 [patent_title] => 'Prostatic growth factor' [patent_app_type] => B2 [patent_app_number] => 09/361741 [patent_app_country] => US [patent_app_date] => 1999-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12517 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/500/06500638.pdf [firstpage_image] =>[orig_patent_app_number] => 09361741 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/361741
Prostatic growth factor Jul 27, 1999 Issued
Array ( [id] => 1457664 [patent_doc_number] => 06391285 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-21 [patent_title] => 'Antimicrobial polypeptide and methods of use' [patent_app_type] => B1 [patent_app_number] => 09/361900 [patent_app_country] => US [patent_app_date] => 1999-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5519 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/391/06391285.pdf [firstpage_image] =>[orig_patent_app_number] => 09361900 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/361900
Antimicrobial polypeptide and methods of use Jul 26, 1999 Issued
Array ( [id] => 6656570 [patent_doc_number] => 20030009777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => 'GALANIN' [patent_app_type] => new [patent_app_number] => 09/230463 [patent_app_country] => US [patent_app_date] => 1999-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 3070 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20030009777.pdf [firstpage_image] =>[orig_patent_app_number] => 09230463 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/230463
GALANIN Jul 25, 1999 Abandoned
09/329531 DNA ENCODING CYTOKINE DESIGNATED LERK-5 Jun 9, 1999 Abandoned
09/327745 METHODS FOR ALTERING CIRCADIAN RHYTHMS AND METHODS FOR PHOSPHORYLATING HUMAN CLOCK PROTEIN, PERIOD 1, BY HUMAN CASEIN KINASE IE Jun 7, 1999 Abandoned
Array ( [id] => 1354702 [patent_doc_number] => 06572866 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-03 [patent_title] => 'Nerve growth factor as a vaccine adjuvant' [patent_app_type] => B1 [patent_app_number] => 09/269883 [patent_app_country] => US [patent_app_date] => 1999-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 10703 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/572/06572866.pdf [firstpage_image] =>[orig_patent_app_number] => 09269883 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/269883
Nerve growth factor as a vaccine adjuvant May 31, 1999 Issued
Array ( [id] => 1545709 [patent_doc_number] => 06444643 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-03 [patent_title] => 'Methods of using inhibitors of cyclophilin rotamase activity to affect neurological activity' [patent_app_type] => B1 [patent_app_number] => 09/321762 [patent_app_country] => US [patent_app_date] => 1999-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5280 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/444/06444643.pdf [firstpage_image] =>[orig_patent_app_number] => 09321762 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/321762
Methods of using inhibitors of cyclophilin rotamase activity to affect neurological activity May 27, 1999 Issued
Array ( [id] => 1542232 [patent_doc_number] => 06372487 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-16 [patent_title] => 'Polynucleotides encoding peptide release factor, prfC (RF-3), a GTP-binding protein' [patent_app_type] => B1 [patent_app_number] => 09/315720 [patent_app_country] => US [patent_app_date] => 1999-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11083 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/372/06372487.pdf [firstpage_image] =>[orig_patent_app_number] => 09315720 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/315720
Polynucleotides encoding peptide release factor, prfC (RF-3), a GTP-binding protein May 19, 1999 Issued
Array ( [id] => 975314 [patent_doc_number] => 06933122 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-08-23 [patent_title] => 'A-form of cytoplasmic domain of nARIA (CRD-neuregulin) and uses thereof' [patent_app_type] => utility [patent_app_number] => 09/312596 [patent_app_country] => US [patent_app_date] => 1999-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 46 [patent_no_of_words] => 24106 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/933/06933122.pdf [firstpage_image] =>[orig_patent_app_number] => 09312596 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/312596
A-form of cytoplasmic domain of nARIA (CRD-neuregulin) and uses thereof May 13, 1999 Issued
Array ( [id] => 4302323 [patent_doc_number] => 06326170 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-04 [patent_title] => 'Prokaryotic polynucleotides, polypeptides and their uses' [patent_app_type] => 1 [patent_app_number] => 9/308003 [patent_app_country] => US [patent_app_date] => 1999-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33408 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/326/06326170.pdf [firstpage_image] =>[orig_patent_app_number] => 308003 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/308003
Prokaryotic polynucleotides, polypeptides and their uses May 9, 1999 Issued
Array ( [id] => 4405935 [patent_doc_number] => 06238873 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-29 [patent_title] => 'Methods of screening for agonists and antagonists of the interaction between the human KIAA0001 receptor and ligands thereof' [patent_app_type] => 1 [patent_app_number] => 9/303524 [patent_app_country] => US [patent_app_date] => 1999-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11456 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/238/06238873.pdf [firstpage_image] =>[orig_patent_app_number] => 303524 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/303524
Methods of screening for agonists and antagonists of the interaction between the human KIAA0001 receptor and ligands thereof Apr 29, 1999 Issued
Array ( [id] => 5987304 [patent_doc_number] => 20020099008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'METHOD FOR STIMULATING HEMATOPOIESIS USING TGF-ALPHA' [patent_app_type] => new [patent_app_number] => 09/299473 [patent_app_country] => US [patent_app_date] => 1999-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8467 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20020099008.pdf [firstpage_image] =>[orig_patent_app_number] => 09299473 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/299473
METHOD FOR STIMULATING HEMATOPOIESIS USING TGF-ALPHA Apr 25, 1999 Abandoned
09/284749 METHOD FOR THE IDENTIFICATION OF COMPOUNDS WITH ANXIOLYTIC POTENTIAL Apr 19, 1999 Abandoned
Array ( [id] => 6618258 [patent_doc_number] => 20020086009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => 'ANTI-PHOSPHORYLATED TAU PROTEIN ANTIBODIES AND METHODS FOR DETECTING ALZHEIMER`S DISEASE WITH THE USE OF THE SAME' [patent_app_type] => new [patent_app_number] => 09/142613 [patent_app_country] => US [patent_app_date] => 1999-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9111 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20020086009.pdf [firstpage_image] =>[orig_patent_app_number] => 09142613 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/142613
ANTI-PHOSPHORYLATED TAU PROTEIN ANTIBODIES AND METHODS FOR DETECTING ALZHEIMER`S DISEASE WITH THE USE OF THE SAME Apr 18, 1999 Abandoned
Array ( [id] => 4222016 [patent_doc_number] => 06040428 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-21 [patent_title] => 'Porcine E-selectin' [patent_app_type] => 1 [patent_app_number] => 9/276197 [patent_app_country] => US [patent_app_date] => 1999-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 17441 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/040/06040428.pdf [firstpage_image] =>[orig_patent_app_number] => 276197 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/276197
Porcine E-selectin Mar 24, 1999 Issued
Menu